Literature DB >> 1221103

Antifibrinolytic therapy in the treatment of subarachnoid haemorrhage caused by arterial aneurysms.

G Profeta, F Castellano, L Guarnieri, A Cigliano, A Amborsio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1221103

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


× No keyword cloud information.
  6 in total

1.  Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.

Authors:  S A Tsementzis; E R Hitchcock; C H Meyer
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 2.  Antifibrinolytic treatment in subarachnoid haemorrhage: present state.

Authors:  H Fodstad
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

3.  Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study.

Authors:  G Pinna; A Pasqualin; C Vivenza; R Da Pian
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

4.  Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.

Authors:  H Fodstad
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

5.  Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm.

Authors:  A A Ameen; R Illingworth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

Review 6.  Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.

Authors:  Merih I Baharoglu; Menno R Germans; Gabriel J E Rinkel; Ale Algra; Marinus Vermeulen; Jan van Gijn; Yvo B W E M Roos
Journal:  Cochrane Database Syst Rev       Date:  2013-08-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.